FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028656286> ?p ?o ?g. }

• W2028656286 endingPage "115" @default.
• W2028656286 startingPage "108" @default.
• W2028656286 abstract "Childhood acute lymphoblastic leukemia (ALL) survivors represent a specific group at risk for many health problems, including skeletal complications and osteoporosis. The objective of this study was to assess the risk of osteoporosis associated with the prevalence of low bone mass (according to the guidelines of the Pediatric Official Positions of the International Society for Clinical Densitometry 2007) in survivors of childhood ALL. The cross-sectional study was conducted in a cohort of 69 Caucasian children and adolescents (46 boys and 23 girls) aged 12.15 ± 0.5yr diagnosed with ALL and screened up to 5 yr after cessation of the treatment. Total body bone mineral content (TB BMC, g), total body bone mineral density (TB BMD, g/cm(2)), and lumbar spine BMD (LS BMD, g/cm(2)) were determined using dual-energy X-ray absorptiometry. Time interval from the completion of the treatment to the beginning of this study (subgroup I<2 yr or subgroup II>2 yr after treatment), methotrexate (MTX) doses (subgroup I-MTX ranging from 0.5 to 1.0g/m(2); subgroup II-MTX>2.0 g/m(2)), cranial irradiation (subgroup I-without radiotherapy (RTX) and subgroup II receiving RTX of 12-18 Gy), cumulative steroid dose, and impaired endocrine function were considered as potential factors affecting bone metabolism and included in the analysis. No differences were found in bone traits (BMC, TB BMD, LS BMD) in relation to examined risk factors. In multiple regression model that included therapeutical factors, a risk group and central nervous system irradiation were of an important influence on bone mass, and risk group predicted TB BMD in small degree. Risk group and irradiation status lost their significance after the inclusion of anthropometric, age-connected, and time-connected factors. This study suggests that ALL survivors are not at increased risk for low bone mass. However, from the clinical perspective all patients after childhood ALL should be screened for clinical signs, fracture history, and lifestyle risk factors for low bone mass and osteoporosis. They should be referred to bone density evaluation only as often as may be necessary from the clinical evaluation." @default.
• W2028656286 created "2016-06-24" @default.
• W2028656286 creator A5022064622 @default.
• W2028656286 creator A5023068671 @default.
• W2028656286 creator A5032725451 @default.
• W2028656286 creator A5054207725 @default.
• W2028656286 creator A5061924630 @default.
• W2028656286 date "2012-01-01" @default.
• W2028656286 modified "2023-09-25" @default.
• W2028656286 title "Little Evidence of Low Bone Mass in Acute Lymphoblastic Leukemia Survivors" @default.
• W2028656286 cites W1561307879 @default.
• W2028656286 cites W1872798817 @default.
• W2028656286 cites W1971597766 @default.
• W2028656286 cites W1973592158 @default.
• W2028656286 cites W1995846491 @default.
• W2028656286 cites W2001536124 @default.
• W2028656286 cites W2005706884 @default.
• W2028656286 cites W2012207856 @default.
• W2028656286 cites W2018034191 @default.
• W2028656286 cites W2026058273 @default.
• W2028656286 cites W2029717087 @default.
• W2028656286 cites W2033246075 @default.
• W2028656286 cites W2040956950 @default.
• W2028656286 cites W2044493694 @default.
• W2028656286 cites W2051399954 @default.
• W2028656286 cites W2051936754 @default.
• W2028656286 cites W2075955953 @default.
• W2028656286 cites W2085775166 @default.
• W2028656286 cites W2086313095 @default.
• W2028656286 cites W2089397228 @default.
• W2028656286 cites W2101257093 @default.
• W2028656286 cites W2105362750 @default.
• W2028656286 cites W2112452649 @default.
• W2028656286 cites W2112551680 @default.
• W2028656286 cites W2113810245 @default.
• W2028656286 cites W2128557725 @default.
• W2028656286 cites W2130607534 @default.
• W2028656286 cites W2135680663 @default.
• W2028656286 cites W2138166278 @default.
• W2028656286 cites W2140365825 @default.
• W2028656286 cites W2147017584 @default.
• W2028656286 cites W2147494639 @default.
• W2028656286 cites W2152788645 @default.
• W2028656286 cites W2154162565 @default.
• W2028656286 cites W2161700402 @default.
• W2028656286 cites W2171831014 @default.
• W2028656286 cites W2315998147 @default.
• W2028656286 cites W2915268865 @default.
• W2028656286 cites W4241161802 @default.
• W2028656286 cites W4245998417 @default.
• W2028656286 doi "https://doi.org/10.1016/j.jocd.2011.07.004" @default.
• W2028656286 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21880524" @default.
• W2028656286 hasPublicationYear "2012" @default.
• W2028656286 type Work @default.
• W2028656286 sameAs 2028656286 @default.
• W2028656286 citedByCount "9" @default.
• W2028656286 countsByYear W20286562862013 @default.
• W2028656286 countsByYear W20286562862014 @default.
• W2028656286 countsByYear W20286562862015 @default.
• W2028656286 countsByYear W20286562862016 @default.
• W2028656286 countsByYear W20286562862019 @default.
• W2028656286 countsByYear W20286562862021 @default.
• W2028656286 crossrefType "journal-article" @default.
• W2028656286 hasAuthorship W2028656286A5022064622 @default.
• W2028656286 hasAuthorship W2028656286A5023068671 @default.
• W2028656286 hasAuthorship W2028656286A5032725451 @default.
• W2028656286 hasAuthorship W2028656286A5054207725 @default.
• W2028656286 hasAuthorship W2028656286A5061924630 @default.
• W2028656286 hasConcept C126322002 @default.
• W2028656286 hasConcept C136496925 @default.
• W2028656286 hasConcept C187212893 @default.
• W2028656286 hasConcept C187960798 @default.
• W2028656286 hasConcept C2776541429 @default.
• W2028656286 hasConcept C2776886416 @default.
• W2028656286 hasConcept C2779329777 @default.
• W2028656286 hasConcept C44249647 @default.
• W2028656286 hasConcept C71924100 @default.
• W2028656286 hasConcept C72563966 @default.
• W2028656286 hasConceptScore W2028656286C126322002 @default.
• W2028656286 hasConceptScore W2028656286C136496925 @default.
• W2028656286 hasConceptScore W2028656286C187212893 @default.
• W2028656286 hasConceptScore W2028656286C187960798 @default.
• W2028656286 hasConceptScore W2028656286C2776541429 @default.
• W2028656286 hasConceptScore W2028656286C2776886416 @default.
• W2028656286 hasConceptScore W2028656286C2779329777 @default.
• W2028656286 hasConceptScore W2028656286C44249647 @default.
• W2028656286 hasConceptScore W2028656286C71924100 @default.
• W2028656286 hasConceptScore W2028656286C72563966 @default.
• W2028656286 hasIssue "1" @default.
• W2028656286 hasLocation W20286562861 @default.
• W2028656286 hasLocation W20286562862 @default.
• W2028656286 hasOpenAccess W2028656286 @default.
• W2028656286 hasPrimaryLocation W20286562861 @default.
• W2028656286 hasRelatedWork W2057835973 @default.
• W2028656286 hasRelatedWork W2081115542 @default.
• W2028656286 hasRelatedWork W2229073733 @default.
• W2028656286 hasRelatedWork W2412783504 @default.
• W2028656286 hasRelatedWork W2421733334 @default.

• next